tored after one dose of Cathflo Activase, a second dose of equal amount may be instilled. Repeat the procedure beginning with Step 1 under Preparation of Solution.
7.If catheter function has been restored, aspirate 4–5 mL of blood in patients ≥10 kg or 3 mL in patients <10 kg to remove Cathflo Activase and residual clot, and gently irrigate the catheter with 0.9% Sodium Chloride, USP.
Any unused solution should be discarded.
Stability and Storage
Store lyophilized Cathflo Activase at refrigerated temperature (2–8°C/36–46°F). Do not use beyond the expiration date on the vial. Protect the lyophilized material during extended storage from excessive exposure to light.
HOW SUPPLIED
Cathflo Activase is supplied as a sterile, lyophilized powder in 2mg vials.
Each Cathflo®Activase® carton contains one 2mg vial of Cathflo® Activase® (Alteplase): NDC 50242‑041‑64.
Each NOVAPLUS™ Cathflo® Activase® carton contains one 2 mg vial of NOVAPLUS™ Cathflo® Activase® (Alteplase): NDC 50242‑041‑65.
http://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=91ecdef2-95ff-42dd-a31c-c8a09cab3ad9 |
